Mammoth Biosciences has developed a CRISPR-based COVID19 test, which can be conducted in 30 min, and is trying to expand to being available at the point of care. https://mammoth.bio/wp-content/uploads/2020/03/Mammoth-Biosciences-A-protocol-for-rapid-detection-of-SARS-CoV-2-using-CRISPR-diagnostics-DETECTR.pdf …
-
Show this thread
-
Replying to @s_r_constantin @ESYudkowsky
I’m hoping for an ELISA assay soon. Like the rapid flu and strep tests widely available at point of care
1 reply 0 retweets 2 likes
Replying to @VaelinVanGogh @ESYudkowsky
They exist but aren’t yet approved.
8:27 AM - 15 Mar 2020
0 replies
0 retweets
1 like
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.